Back to Results
First PageMeta Content



December 21, 2015 Press release Mitsubishi Tanabe Pharma Corporation Remicade® for I.V. Infusion 100 Approval of Additional Indication for Kawasaki Disease
Add to Reading List

Document Date: 2015-12-21 01:49:29


Open Document

File Size: 220,70 KB

Share Result on Facebook